Practical Feasibility of Screening for Critical Congenital Heart Disease in Newborns With Pulse Oximetry A de-Wahl Granelli 1 , M Mellander 1 , J Sunnegårdh 1 , K Sandberg 2 , I Östman-Smith 1 Department of Paediatric Cardiology 1 , Department of Neonatology 2 ,
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Practical Feasibility of Screening for Critical
Congenital Heart Disease in Newborns
With Pulse Oximetry
A de-Wahl Granelli1, M Mellander1, J Sunnegårdh1, K Sandberg2, I Östman-Smith1
Department of Paediatric Cardiology1, Department of Neonatology2,
The Queen Silvia Children’s Hospital, Göteborg, Sweden
Many babies with duct-dependent critical congenital heart disease (CCHD) are not detected by routine neonatal physical examination. There is a need for an additional tool to enable an early detection of CCHD. Our aim is to define an optimal screening regime using pulse oximetry.
(A) In an initial case-control study, 200 normal newborns and 85 infants with CCHD were compared to calculate optimal cut-off values. A pulse oximetry reading was obtained from the right hand and one foot using a new-generation oximeter (NGoxi), Fig 1A and B. (B) Prospective screening of all babies in the newborn nurseries in our region with NGoxi, using the defined cut-off from (A) but with introduction of three repeated positive measurements into the protocol.
Fig 1 A and B
<95% in both Right hand & foot
hand-foot difference >+ 3%
Positive Predictive Value 91%
Negative Predictive Value 99%
83/85 infants with CCHD were detected using NGoxi, including 9/11 infants with coarctation of the aorta (CoA).
(B)Preliminarydata from ongoing study on 8642 newborns show a significant reduction of the false positive rate from 4% to 0.14%. We have detected five out of six infants with duct-dependent CCHD, the false negative case had isolated CoA. Among the12 “false positive” cases we found one Ebstein anomaly, one AVSD, one Sinus venousus ASD, one infant with persistant fetal circulation and one with pneumothorax. All of them needed treatment.
A pre- and postductal saturation screening with NGoxi before discharge from the newborn nurseries seems to be a promising tool to detect CCHD with a very low false positive rate. The study also detected infants suffering from other conditions, that also benefits from early detection.